Pharmaceutical Exports Amounted To US$426.3 Million, Indicating That Much of the Market Is Import Driven - The Pharmaceutical Market: Finland.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c49789) has announced the addition of The Pharmaceutical Market: Finland to their offering. This in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. Topics Covered: 1. Executive Summary 2. Pharmaceutical Market 3. Key National Data Projections 4. Geography 5. Political Overview 6. Economic Overview 7. Population 8. Demographic Indicators 9. Mortality 10. Morbidity morbidity /mor·bid·i·ty/ (mor-bid´it-e) 1. a diseased condition or state. 2. the incidence or prevalence of a disease or of all diseases in a population. mor·bid·i·ty n. 11. Organisation & Administration 12. Health Expenditure 13. Hospital Services 14. Ambulatory Care ambulatory care n. Medical care provided to outpatients. ambulatory care, n the health services provided on an outpatient basis to those who can visit a health care facility and return home the same day. 15. Medical Personnel 16. Regulatory Environment 17. Distribution Channels 18. Pharmaceutical Imports 19. Domestic Production & Exports 20. Directory The principal regulatory body in Finland is the National Agency for Medicines (NAM), operating under the Ministry for Social Affairs and Health. All pharmaceutical products, available on the domestic market and exported, must receive authorisation from NAM. NAM regulations stipulate stip·u·late 1 v. stip·u·lat·ed, stip·u·lat·ing, stip·u·lates v.tr. 1. a. To lay down as a condition of an agreement; require by contract. b. conditions on the basis of quality, safety and effectiveness. The principal authority regarding application for reimbursable re·im·burse tr.v. re·im·bursed, re·im·burs·ing, re·im·burs·es 1. To repay (money spent); refund. 2. To pay back or compensate (another party) for money spent or losses incurred. status is the Pharmaceutical Pricing Board, affiliated to the Ministry of Social Affairs and Health. Other matters concerning reimbursable status are dealt with by the Social Insurance Institution (SII SII Servicio de Impuestos Internos (Chile) SII Seiko Instruments, Inc. SII Strong Interest Inventory SII Standards Institution of Israel SII Securities and Investment Institute (UK) ). The NAM is viewed as a respected agency in the Mutual Recognition Procedure and is the leading agency in the EU as a reference state in the role of marketing authorisations. The level of reimbursements has increased over the course of the past few years. In 2004, reimbursements were equal to 1,014.6 million euros (US$1,260.0 million), an increase of 10.6% over 2003. Many reasons have been given for this but of primary importance is the basic structure of the reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. system. The vast majority of imports are in the form of retail medicaments, accounting for 93.7% of the US$1.2 billion of pharmaceuticals imported from a wide range of countries in 2003. Pharmaceutical exports amounted to US$426.3 million, indicating that much of the market is import driven. For more information visit http://www.researchandmarkets.com/reports/c49789 Source: Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion